ZAP-X

GYROSCOPIC RADIOSURGERY®
FOR THE BRAIN

Leveraging unique gyroscopic motion, the ZAP-X® platform opens new frontiers in modern radiosurgery. Combining self-shielding technology with high dose rate linear-accelerator delivery, ZAP-X was created to safely treat more patients in more places.

NEXT

ZAP-X is what’s next in non-invasive cancer treatment. It enables neurosurgeons and radiation oncologists to change precision radiation for the better. Designed exclusively for the streamlined treatment of brain tumors and conditions of the head and neck, ZAP-X redefines the future of radiosurgery.

ZAP-X® 3/4 Top View
Self-Shielded

Self-Shielded

As the first-in-kind “vault-free” radiosurgery system, ZAP-X obviates the need for costly radiation bunkers. Enabling simple department expansions, ZAP-X now also makes radiosurgery feasible for point of care delivery at virtually any location—including satellite facilities, physician offices and ambulatory surgery centers.

LINAC-Based

LINAC-Based

Using state-of-the-art linear accelerator (LINAC) technology, ZAP-X uniquely provides diverse non-coplanar radiation dose delivery while eliminating the need for live radioactive sources. No more costly source replacements, and no more ongoing regulatory and security burden.

SRS-Optimized

SRS-Optimized

Meticulously designed with a low scatter beam energy, a low penumbra source-axis distance, and ultra-low collimation leakage, ZAP-X was purpose-built for world-class cranial radiosurgery – without the compromises and complexities of multi-purpose radiotherapy systems.

Better Economics

Better Economics

Blending significantly lower system, facility and operating expenses with well-established reimbursement, ZAP-X removes historical constraints to now put world-class radiosurgery within reach of more providers, and more patients.

THAT WAS THEN. THIS IS NEXT.
ZAP-X GYROSCOPIC RADIOSURGERY.

NEWS & PRESS

ZAP Surgical Receives CE Mark Clearance for its ZAP-X Gyroscopic Radiosurgery Platform

Critical Milestone Enables Next-Gen Non-Invasive Brain Tumor Treatments in Europe

ZAP Surgical Announces First Facility on the East Coast Initiates Patient Treatment Using New Non-Invasive Brain Tumor Therapy

MedStar Southern Maryland Hospital Center Becomes 2nd Provider in the United States to Offer Advanced ZAP-X Gyroscopic Radiosurgery

ZAP Surgical’s Gyroscopic Radiosurgery Platform Receives Japanese Shonin Approval

Partnerships with MC Medical and Chiyoda Technol to Provide Sales and Technical Support of Next-Gen Non-Invasive Brain Cancer Treatments

ZAP Surgical Brain Tumor Treatments Commence at PLA General Hospital 301 in Beijing, China

Clinical Trial Underway for Next-Gen Vault-Free Stereotactic Radiosurgery Platform

RESEARCH

Peer-reviewed, open-access publications documenting the technical details and specifications of the ZAP-X treatment planning and delivery platform.

zap-x-radiosurgical-system-in-the-treatment-of-intracranial-tumors

The Zap-X Radiosurgical System in the Treatment of Intracranial Tumors: A Technical Case Report

Longsheng Pan, MD ; Baolin Qu, MD; Jingmin Bai, MD; Lichao Huang, MD; Jinyuan Wang, MS

characterization-of-a-novel-3-megavolt-linear-accelerator-for-dedicated-intracranial-stereotactic-radiosurgery

Characterization of a Novel 3 Megavolt Linear Accelerator for Dedicated Intracranial Stereotactic Radiosurgery

Georg A. Weidlich, Mohan Bodduluri, Younes Achkire, Chris Lee, John R. Adler Jr.

ZAP-X: A Novel Radiosurgical Device for the Treatment of Trigeminal Neuralgia

ZAP-X: A Novel Radiosurgical Device for the Treatment of Trigeminal Neuralgia

Pantaleo Romanelli, Cynthia Chuang, Antonio Meola, Radhika M. Bodduluri, John R. Adler Jr.

self-shielding-analysis-of-the-zap-x-system2x

Self-Shielding Analysis of the Zap-X System

Georg A. Weidlich, M. Bret Schneider, John R. Adler

ABOUT ZAP SURGICAL SYSTEMS

At ZAP®, we know a thing or two about what comes next. In everything, we are a team motivated by a single question: Can a device address the limitations of the past to treat more people in more places? We believe it can. We believe the ZAP-X platform defines what’s next in radiosurgery for the brain. We are ZAP.

JOHN R. ADLER, MD, FOUNDER & CEO

Professor of Neurosurgery and Radiation Oncology at Stanford University, John R. Adler, MD, is the co-inventor of ZAP-X and a renowned pioneer in the field of radiosurgery. Inventor of the CyberKnife® System and founder of Accuray, Inc., Dr. Adler’s life work is focused on finding smarter solutions for physicians and their patients. In 2018, Dr. Adler was awarded the American Association of Neurological Surgeons (AANS) Cushing Award for Technical Excellence and Innovation in Neurosurgery.

CONTACT

Want to learn more about the ZAP-X® Gyroscopic Radiosurgery® platform, or about the latest radiosurgical procedures and treatments? Please tell us a little about you and your practice.

The ZAP-X® Gyroscopic Radiosurgery® platform received U.S. FDA 510(k) clearance in 2017 and Japan Shonin clearance in 2020. It is currently not available in all markets. System shielding requirements may vary by country.

ZAP-X® Instructions for Use

ZAP® Makers of ZAP-X® Gyroscopic Radiosurgery for the Brain.

ZAP Surgical Systems, Inc.
590 Taylor Way, San Carlos, CA 94070

ZAP,  ZAP-X, the Z symbol, and GYROSCOPIC RADIOSURGERY are registered trademarks of ZAP Surgical Systems, Inc.
©2021 All rights reserved. Terms and Conditions

Privacy Policy